Tech Company Financing Transactions
Accure Therapeutics Funding Round
On 4/7/2025, Accure Therapeutics raised $1.6 million in funding from The Michael J. Fox Foundation for Parkinson's Research.
Transaction Overview
Company Name
Announced On
4/7/2025
Transaction Type
Debt
Amount
$1,600,000
Round
Undisclosed
Proceeds Purpose
Funding will be used to finalise the preclinical activities required for completing investigational new drug (IND) studies, with a view to filing an application for a phase I IND study in 2026.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Torres R+D+I, Baldiri Reixac 4-8,
Barcelona, 08028
Spain
Barcelona, 08028
Spain
Phone
Website
Email Address
Overview
Accure Therapeutics is committed to deliver efficiently new disease modifiers therapies to patients, i.e. new medicines able to change the course of severe orphan and non-orphan CNS diseases. A new medicine R&D engine (R&D pharma company) operated by an experienced team dedicated to the discovery and development of new medicines to treat patient suffering from severe diseases of the central nervous system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laurent Nguyen
Browse more venture capital transactions:
Prev: 4/7/2025: Metopio venture capital transaction
Next: 4/7/2025: Janover venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs